Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Analyst
Gabe Hajde
Period: Reporting periods mapped to calendar 2024 Q4 – 2026 Q2 (7 quarters).
- Questions
- 35on tracked calls
- Challenge rate
- 20%7 of 35 questions
- Companies
- 5questioned at least once
- Reporting periods
- 7with questions
These figures cover the whole profile: every tracked question, all reporting periods.
How to read these numbers
Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.
Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.
No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.
Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.
Small samples. Profiles with fewer than 10 questions are marked Limited sample.
Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.
Questions asked
Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.
Showing 35 of 35 questions from 5 companies
SWSmurfit WestRock14 questions · 7 reporting periods · 0 of 14 challenging
Calendar 2026 Q2
assuming the bottom doesn’t fall out in volumes, that you should inflect positive at some point in the second half
Show response
Tony committed to a specific timeframe and named the driver, easier e-commerce comparisons plus new business wins, though he did not break out markets.
how much tracked price or what you would expect sort of realization from just what’s been recognized in RECI
Show response
Ken explained the paperboard/SBS decline offsets corrugated gains this quarter, with recovery weighted to Q3 and Q4. Direct and specific on the mechanics.
Calendar 2026 Q1
Just want to confirm on the most recent price announcement that RISI picked up for June implementation. It is kind of standard practice for you all to not embed that into your outlook until it's re...
Show response
Tony confirmed second $50/ton not fully embedded in guidance but will partly offset material cost increases (freight, energy, supplier costs). Security of supply question returning to customer conversations for first time in a while. Ken updated cost bridge: energy now $270-290M headwind (up from $80M in Feb), freight ~$50M headwind, fiber ~$50M tailwind, labor less of a headwind (~$50M vs $100M expected).
on more of the, I'll call it, open market piece of the containerboard business in North America. Can you talk at all about what you've seen in the export markets in North America
Show response
Tony described dramatic shift in global containerboard market. European paper that was available at any price 3 months ago now unavailable until September. US paper exports to LatAm down ~30%. World containerboard market (~100M tons) growing 1-2% annually with significant capacity removed, shortage emerging as demand strengthens. Expects this to be beneficial as year progresses.
Calendar 2025 Q4
on the downtime, can you remind us what it was for the full year and if you're willing to split it out between the corrugated and the consumer business
Show response
Ken confirmed $220M full-year downtime, declined corrugated/consumer split for disclosure reasons. Q4 was $85M. European utilization target mid-90s, easily achieved given integration. NA target mid-90s, Laurent working actively toward it. Tony said half of 1.2B sq meters lost will be implemented by Q1/early Q2, another half of pipeline expected to convert in 2026 with rest flowing into early 2027.
the margin profile would suggest on the current business about $800 million of improvement. And then the most difficult thing to lock down or pin down has been the 1.6% growth in North America
Show response
Tony attributed ~3-4% of their ~10% volume decline to market weakness, rest to deliberate strategy. Believes US economy is strong and will return to growth. Expects more promotions from branded goods companies to drive box demand. Ken provided helpful rule of thumb: 1% volume growth ≈ ~$60M group EBITDA. Tony endorsed third-party 1.5% NA market growth forecast as doable.
Calendar 2025 Q3
I'm just curious if the organization for the year, if there's anything strategically that you guys are focused more on cash flow for 2026 versus EBITDA
Show response
Ken explained $2.4-2.5B is what the business needs to grow and improve, not a trade-off between cash flow and EBITDA. Portfolio approach avoids concentration. Tony emphasized remaining agile and never overinvesting.
Can you provide a little bit of color in the markets whether it's geographic or end-use markets where you guys are doing particularly well
Show response
Tony described Germany still lagging with occasional false dawns. Eastern Europe and Iberia growing. Ken noted Q3 European box prices ticked up another 0.5%. Future pricing depends on demand, with any changes being a Q2-Q3 2026 event.
Calendar 2025 Q2
another quarter under the belt and thinking about sort of the opportunity set there to be on both sides of the house in terms of consumer and corrugated
Show response
Tony sees strong cross-selling opportunity especially in Europe where they're more advanced. Consumer team gaining selling tools from corrugated innovation. SBS long position strategic update expected late 2025 or early 2026.
maybe put a little bit more of a finer point on some of the underlying assumptions sort of in the 1.3
Show response
Ken broke down Q3 bridge: $50M lower downtime + $50M recovered fiber relief. Flat volume assumption, no price baked in. Full year: energy headwind improved from $350M to $250M, recovered fiber from $155M to $105-110M, labor slightly better. Tony expects flat H2 vs H1 volumes.
Calendar 2025 Q1
First quarter, again, margins really good. Just curious, kind of from a timing phasing standpoint, I'm assuming second half kind of stronger than first half
Show response
Ken explained paper-to-box price lag of 3-6 months, meaning H2 paper price increases won't hit box prices until Q4/early next year. Now closer to 60-40 index/non-index vs prior 50-50. Tony noted new competitor machines not yet in market, expected in 3-4 months.
I don't recall if I saw a timeline associated with it. And, Ken, you rattled off a lot of numbers
Show response
Ken confirmed $50-60M aggregate EBITDA benefit from both mill closures plus $100M CapEx avoided over five years. The $400M+ operational improvement is the second bucket beyond synergies. Tony added asset values underneath the mills will recover at least 50% of cash cost.
Calendar 2024 Q4
Price discovery in North America, how important is that process kind of on a more medium-term basis? And at this point, do you guys sort of envision trying to decouple from some of the benchmarks
Show response
Tony explained they're partially decoupling by addressing individual mispricing but still using RISI as benchmark since no better alternative exists. Ken detailed shift from blended to individual mill/box plant margins.
is there a way to think about waiting for -- and then maybe taking into account just maintenance. You mentioned I think $10 million lower on a sequential basis into the first quarter, but weighting...
Show response
Ken indicated broadly similar quarterly phasing with upside potential from paper price recovery in H2. Tony noted typical seasonal pattern of busier spring/summer/fall months.
PKGPackaging Corporation of America11 questions · 6 reporting periods · 3 of 11 challenging
Calendar 2026 Q2
how would you describe kind of the feel in the market right now from a supply demand standpoint?
Show response
Hassfurther summarized the supply/demand environment in one word: tight.
Calendar 2025 Q4
can you just talk about, let's say, an impromptu mill rebuild in 3.5 weeks. Was that part of the plan?
Show response
Mark confirmed PCA deliberately accelerated corrective action leveraging their technology engineering group, learning from Boise acquisition experience. Kent said Greif expected to be slightly accretive in Q1 and improving through the year with seasonality.
directionally, would we expect things to be flattish next year on CapEx or down?
Show response
Mark's goal is to bring CapEx below $800M. Gas turbines keep it higher near-term. Box plant projects finishing. Wants organizational discipline to pause and optimize recent investments. Historical precedent: lowered to $600M in 2022-2023 before ramping again.
There seems to be a clear inflection in your tone. I'm curious if you can, is this something specific to what PCA is doing
Show response
Tom acknowledged more positive vibe across entire customer base. 2025 was unusual with start-stop ordering driven by tariff/import uncertainty. That has largely cleared. February also remains very strong. Could not definitively separate PCA-specific vs market-wide improvement.
Calendar 2025 Q3
running kind of around $1 year-to-date. So I think in this quarter, it was $0.33. So if I annualize that, we're looking at kind of $170 million
Show response
Mark highlighted electricity as biggest cost factor. Kent added labor, chemicals, supplies, insurance, rent. Mark doesn't see electricity costs abating due to data center demand. Planning 3 gas turbine projects to take mills off-grid within 2.5 years with 1.5-year payback.
how sensitive are customers in terms of potential price increases or trying to do more with less, whether it's lightweighting
Show response
Tom declined to discuss forward pricing. Highlighted PCA proprietary lightweighting technology as competitive advantage, solutions taken to customers to fight inflation. Mills expected to meet stringent specifications enabling these capabilities.
Calendar 2025 Q2
I'm just curious if you're seeing more instances of bidding out there given sort of what appears to be a little bit of a volatile environment
Show response
Tom said business as usual on bidding. Noted industry supply now very much in line with demand given recent mill/plant closures.
Anything specific on the Greif acquisition from a financial standpoint, cash tax specifically, that could be advantageous to you
Show response
Kent confirmed asset acquisition structure provides depreciation shield. Bonus depreciation at higher level under Big Beautiful Bill. Modeled ~5.5% interest on new debt.
Calendar 2025 Q1
I'm just curious, it sounds like there were some increases that from a contractual standpoint that were put through if you are willing to comment
Show response
Mark confirmed CapEx tracking to guide. Bob said 3 rail increases in Q1 with 3 more in Q2. Ohio plant broke ground in February.
Calendar 2024 Q4
I'm seeing about $50 a ton of price realization in the fourth quarter -- excuse me, in 2024, which would imply sort of $30 million of unfavorable mix
Show response
Bob explained the math is closer to mid-$50s per ton when accounting for inventory, export/domestic mix, and the prior $20/ton decline in late 2023.
Mark, are you telling us there is no incremental capacity on the containerboard side in 2025, no debottlenecking or anything like that in that CapEx number?
Show response
Mark confirmed mill optimization projects are ongoing plus four big box plant projects. About $250M of CapEx going to the four big projects this year.
IPInternational Paper4 questions · 2 reporting periods · 2 of 4 challenging
Calendar 2026 Q2
would you say that there are still other options that could be pursued or evaluated as part of that process?
Show response
Andy reaffirmed the spin as the priority but left the door open to an appropriate approach on fiduciary grounds.
have you actioned everything on the cost side to get you to that $1.2 billion and on an exit rate
Show response
Andy quantified carryover of $350 million to $400 million in NA and $200 million to $250 million in Europe, and said demand is 4% to 5% below original expectations.
Calendar 2024 Q4
you are not including any price as it relates to the January increases because it was not reflected in RISI
Show response
Silvernail confirmed no January price increase impacts are included in the Q1 outlook, as they were not yet reflected in published indexes.
When should we expect that IP starts to catch up that $1.2 billion of underspend?
Show response
Silvernail estimates 3 years to close the CapEx underinvestment gap, constrained by organization's ability to effectively spend rather than dollar availability.
AMCRAmcor3 questions · 3 reporting periods · 0 of 3 challenging
Calendar 2026 Q2
it looks like CapEx is starting to accelerate here in the first half.
Show response
Steve confirmed mid-single-digit EBITDA growth is implied over the transition and 18-month period, driven by synergies plus modest volume growth, landing within the analyst's $3.8-4.0 billion range, and framed CapEx at a steady ~5% of sales to support organic growth, not materially above historic levels.
Calendar 2026 Q1
I think health care specifically was intended to improve kind of beginning in the middle of 2026. Can you comment on that
Show response
PK clarified healthcare was the one weaker focus category. US winter storms impacted production and customer pull-through. Weaker cold/flu season also a factor. Multiple positive wins including pharma contracts, GLP-1, generics sustainability partnership, new Malaysia coating facility. Non-focus nutrition weakness in discretionary categories like confectionery.
Calendar 2025 Q3
I just had a question about health care. I think the expectation was that it was going to return to growth kind of in the back half of 2025
Show response
PK described regional divergence: strong NA medical growth offset by weaker European pharma, averaging to flat overall. Pharma recovery lagging medical. Expects continued improvement into calendar 2026 and H2 FY2026. Healthcare remains a strategic priority.
BALLBall Corporation3 questions · 2 reporting periods · 2 of 3 challenging
Calendar 2026 Q2
alcohol as part of the portfolio being about 40% and maybe over time getting closer to 30%
Show response
Hajde asked if reducing alcohol mix remains a goal; Lewis redirected to can share gains, noting beer is neither Ball's only nor biggest category.
Calendar 2025 Q4
First question is the Florida Can acquisition, is that 4.8% an organic number? Or would we say half was kind of from Florida Can and half was organic
Show response
Lewis confirmed Florida Can contributed a small but not immaterial portion of 4.8% growth. No Q4 pull-forward observed, January can market continues growing. Cross-border tariff costs too prohibitive to tap Mexico latent capacity.
is it possible then kind of operating earnings is flattish in North Central America and then we see a pretty big acceleration in '27
Show response
Lewis confirmed flat NA operating earnings framing is directionally right for 2026. Oregon is a one-line plant, expecting aspirationally ~1 billion cans in 2027. Start-up costs in 2026, earnings contribution in 2027.
Challenge rate by company
Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.
| Company | Questions | Challenge rate |
|---|---|---|
| SW Smurfit WestRock | 14 | 0%none of 14 questions |
| PKG Packaging Corporation of America | 11 | 27%3 of 11 questions |
| IP International Paper | 4 | 50%2 of 4 questions |
| AMCR Amcor | 3 | 0%none of 3 questions |
| BALL Ball Corporation | 3 | 67%2 of 3 questions |
Activity by reporting period
Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.
| Calendar period | Questions | Challenge rate | Companies |
|---|---|---|---|
| 2024 Q4 | 6 | 50%3 of 6 questions | 3 |
| 2025 Q1 | 3 | 0%none of 3 questions | 2 |
| 2025 Q2 | 4 | 0%none of 4 questions | 2 |
| 2025 Q3 | 5 | 0%none of 5 questions | 3 |
| 2025 Q4 | 7 | 43%3 of 7 questions | 3 |
| 2026 Q1 | 3 | 0%none of 3 questions | 2 |
| 2026 Q2 | 7 | 14%1 of 7 questions | 5 |
- 2024 Q46 questions · challenge rate 50% (3 of 6 questions) · 3 companies
- 2025 Q13 questions · challenge rate 0% (none of 3 questions) · 2 companies
- 2025 Q24 questions · challenge rate 0% (none of 4 questions) · 2 companies
- 2025 Q35 questions · challenge rate 0% (none of 5 questions) · 3 companies
- 2025 Q47 questions · challenge rate 43% (3 of 7 questions) · 3 companies
- 2026 Q13 questions · challenge rate 0% (none of 3 questions) · 2 companies
- 2026 Q27 questions · challenge rate 14% (1 of 7 questions) · 5 companies
Topics
Topics tagged on this analyst’s questions.
- Demand14
- Competitive Dynamics10
- Pricing8
- Capex Investment6
- Cost Pressure6
- M&A4
- Capital Allocation4
- Revenue Growth3
- Guidance Reliability3
- Margin2
Show all 11 topics
- Supply Chain1